ValiRx - ValiSeek Clinical Development Update
VAL
Thu, 15 Jun 2017, 09:00 BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
Since its last clinical update on 8 March 2017, ValiSeek is pleased to report continued progress of the trial of VAL401 in the treatment of non-small cell lung cancer. ValiSeek has decided now to cease enrolling new participants and will continue to measure the outcomes of those patients still on trial, while commencing analysis of the results to date.
